Rep. Sessions to Newsmax: ‘Race Is On’ With China in Biotech

Rep. Pete Sessions, R-Texas, told Newsmax on Sunday that the United States is locked in a biotechnology race with China and pitched a National Defense Authorization Act provision that would allow the Food and Drug Administration to draw on clinical trial data from allied regulators to speed up American drug approvals. He framed the push as an extension of the 2018 Right to Try Act, which he said helped fuel a wave of biotech startups now central to U.S. innovation. Speaking on Wake Up America Weekend, Sessions highlighted his work with the bipartisan Congressional BIOTECH Caucus, which Reps. Chrissy Houlahan,…